254 related articles for article (PubMed ID: 26418829)
1. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
Cheng W; Tang C; Yin C
J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
[TBL] [Abstract][Full Text] [Related]
2. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages.
Zhang J; Tang C; Yin C
Biomaterials; 2013 May; 34(14):3667-77. PubMed ID: 23419643
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
He C; Yin L; Tang C; Yin C
Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
[TBL] [Abstract][Full Text] [Related]
4. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
5. Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.
Chu S; Tang C; Yin C
Biomaterials; 2015 Jun; 52():229-39. PubMed ID: 25818429
[TBL] [Abstract][Full Text] [Related]
6. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
7. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
He C; Yin L; Song Y; Tang C; Yin C
Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
[TBL] [Abstract][Full Text] [Related]
8. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
[TBL] [Abstract][Full Text] [Related]
9. Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
Attarwala H; Clausen V; Chaturvedi P; Amiji MM
Mol Pharm; 2017 Sep; 14(9):3036-3044. PubMed ID: 28737923
[TBL] [Abstract][Full Text] [Related]
10. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Huang Y; Guo J; Gui S
Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
[TBL] [Abstract][Full Text] [Related]
11. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
12. Effect of binding affinity for siRNA on the in vivo antitumor efficacy of polyplexes.
Han L; Tang C; Yin C
Biomaterials; 2013 Jul; 34(21):5317-27. PubMed ID: 23591392
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
14. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
15. Reduction of inflammation in a chronic periodontitis model in rats by TNF-α gene silencing with a topically applied siRNA-loaded calcium phosphate paste.
Tenkumo T; Rojas-Sánchez L; Vanegas Sáenz JR; Ogawa T; Miyashita M; Yoda N; Prymak O; Sokolova V; Sasaki K; Epple M
Acta Biomater; 2020 Mar; 105():263-279. PubMed ID: 31982590
[TBL] [Abstract][Full Text] [Related]
16. Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.
He C; Yin L; Tang C; Yin C
Pharm Res; 2013 Oct; 30(10):2596-606. PubMed ID: 23715740
[TBL] [Abstract][Full Text] [Related]
17. Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system.
McCarthy J; O'Neill MJ; Bourre L; Walsh D; Quinlan A; Hurley G; Ogier J; Shanahan F; Melgar S; Darcy R; O'Driscoll CM
J Control Release; 2013 May; 168(1):28-34. PubMed ID: 23500058
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
19. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
Wilson DS; Dalmasso G; Wang L; Sitaraman SV; Merlin D; Murthy N
Nat Mater; 2010 Nov; 9(11):923-8. PubMed ID: 20935658
[TBL] [Abstract][Full Text] [Related]
20. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
